Bioventus, Inc. (BVS)
12.93
-0.27
(-2.05%)
USD |
NASDAQ |
Sep 17, 13:15
Bioventus Debt to Equity Ratio : 1.155 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.155 |
| March 31, 2026 | 1.527 |
| December 31, 2025 | 1.691 |
| September 30, 2025 | 2.054 |
| June 30, 2025 | 2.237 |
| March 31, 2025 | 2.402 |
| December 31, 2024 | 2.407 |
| September 30, 2024 | 2.652 |
| June 30, 2024 | 2.616 |
| March 31, 2024 | 2.364 |
| December 31, 2023 | 2.359 |
| September 30, 2023 | 2.31 |
| June 30, 2023 | 2.196 |
| March 31, 2023 | 2.456 |
| December 31, 2022 | 1.340 |
| Date | Value |
|---|---|
| September 30, 2022 | 1.287 |
| June 30, 2022 | 0.8787 |
| March 31, 2022 | 0.8636 |
| December 31, 2021 | 0.8198 |
| September 30, 2021 | 1.283 |
| June 30, 2021 | 1.413 |
| March 31, 2021 | 1.433 |
| December 31, 2020 | 1.437 |
| September 30, 2020 | 1.454 |
| June 30, 2020 | 1.869 |
| March 31, 2020 | |
| December 31, 2019 | 1.499 |
| September 30, 2019 | |
| March 31, 2016 | 1.102 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Accuray, Inc. | 4.502 |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 0.6102 |
| ResMed, Inc. | 0.1254 |
| Rockwell Medical, Inc. | 0.3971 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 673.35M |
| Total Liabilities (Quarterly) | 395.93M |
| Shareholders Equity (Quarterly) | 228.31M |
| Current Ratio | 1.689 |
| Net Debt Paydown Yield | 2.86% |